Tilray price target lowered to $1.25 from $1.75 at Roth MKM

Roth MKM lowered the firm’s price target on Tilray (TLRY) to $1.25 from $1.75 and keeps a Neutral rating on the shares. The company’s Q2 missed estimates, underscoring the core pressures faced, primarily Canadian price compression, the analyst tells investors in a research note. The firm believes Tilray’s reaffirmed guidance will be difficult to achieve, but notes improved space in beer spring resets, international cannabis opportunities, and innovation in Canadian cannabis “offer prospects for meaningful acceleration.”